Literature DB >> 26902206

Systematic Analysis of Intracellular-targeting Antimicrobial Peptides, Bactenecin 7, Hybrid of Pleurocidin and Dermaseptin, Proline-Arginine-rich Peptide, and Lactoferricin B, by Using Escherichia coli Proteome Microarrays.

Yu-Hsuan Ho1, Pramod Shah1, Yi-Wen Chen1, Chien-Sheng Chen2.   

Abstract

Antimicrobial peptides (AMPs) act either through membrane lysis or by attacking intracellular targets. Intracellular targeting AMPs are a resource for antimicrobial agent development. Several AMPs have been identified as intracellular targeting peptides; however, the intracellular targets of many of these peptides remain unknown. In the present study, we used an Escherichia coli proteome microarray to systematically identify the protein targets of three intracellular targeting AMPs: bactenecin 7 (Bac7), a hybrid of pleurocidin and dermaseptin (P-Der), and proline-arginine-rich peptide (PR-39). In addition, we also included the data of lactoferricin B (LfcinB) from our previous study for a more comprehensive analysis. We analyzed the unique protein hits of each AMP in the Kyoto Encyclopedia of Genes and Genomes. The results indicated that Bac7 targets purine metabolism and histidine kinase, LfcinB attacks the transcription-related activities and several cellular carbohydrate biosynthetic processes, P-Der affects several catabolic processes of small molecules, and PR-39 preferentially recognizes proteins involved in RNA- and folate-metabolism-related cellular processes. Moreover, both Bac7 and LfcinB target purine metabolism, whereas LfcinB and PR-39 target lipopolysaccharide biosynthesis. This suggested that LfcinB and Bac7 as well as LfcinB and PR-39 have a synergistic effect on antimicrobial activity, which was validated through antimicrobial assays. Furthermore, common hits of all four AMPs indicated that all of them target arginine decarboxylase, which is a crucial enzyme for Escherichia coli survival in extremely acidic environments. Thus, these AMPs may display greater inhibition to bacterial growth in extremely acidic environments. We have also confirmed this finding in bacterial growth inhibition assays. In conclusion, this comprehensive identification and systematic analysis of intracellular targeting AMPs reveals crucial insights into the intracellular mechanisms of the action of AMPs.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26902206      PMCID: PMC5083092          DOI: 10.1074/mcp.M115.054999

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  45 in total

Review 1.  Breaking through the acid barrier: an orchestrated response to proton stress by enteric bacteria.

Authors:  J P Audia; C C Webb; J W Foster
Journal:  Int J Med Microbiol       Date:  2001-05       Impact factor: 3.473

Review 2.  Insights into enzyme function from studies on mutants of dihydrofolate reductase.

Authors:  S J Benkovic; C A Fierke; A M Naylor
Journal:  Science       Date:  1988-03-04       Impact factor: 47.728

3.  Control of acid resistance in Escherichia coli.

Authors:  M P Castanie-Cornet; T A Penfound; D Smith; J F Elliott; J W Foster
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

4.  Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions.

Authors:  C B Park; H S Kim; S C Kim
Journal:  Biochem Biophys Res Commun       Date:  1998-03-06       Impact factor: 3.575

5.  Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip.

Authors:  Chien-Sheng Chen; Sean Sullivan; Troy Anderson; Aik Choon Tan; Philip J Alex; Steven R Brant; Carmen Cuffari; Theodore M Bayless; Monica V Talor; C Lynne Burek; Huan Wang; Richard Li; Lisa Wu Datta; Yuqiong Wu; Raimond L Winslow; Heng Zhu; Xuhang Li
Journal:  Mol Cell Proteomics       Date:  2009-04-07       Impact factor: 5.911

Review 6.  Lipid A modification systems in gram-negative bacteria.

Authors:  Christian R H Raetz; C Michael Reynolds; M Stephen Trent; Russell E Bishop
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

7.  Antibacterial peptide microcin J25 inhibits transcription by binding within and obstructing the RNA polymerase secondary channel.

Authors:  Jayanta Mukhopadhyay; Elena Sineva; Jennifer Knight; Ronald M Levy; Richard H Ebright
Journal:  Mol Cell       Date:  2004-06-18       Impact factor: 17.970

Review 8.  The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation.

Authors:  Seong-Cheol Park; Yoonkyung Park; Kyung-Soo Hahm
Journal:  Int J Mol Sci       Date:  2011-09-16       Impact factor: 5.923

9.  Identification of lactoferricin B intracellular targets using an Escherichia coli proteome chip.

Authors:  Yu-Hsuan Tu; Yu-Hsuan Ho; Ying-Chih Chuang; Po-Chung Chen; Chien-Sheng Chen
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

10.  The Pfam protein families database.

Authors:  Marco Punta; Penny C Coggill; Ruth Y Eberhardt; Jaina Mistry; John Tate; Chris Boursnell; Ningze Pang; Kristoffer Forslund; Goran Ceric; Jody Clements; Andreas Heger; Liisa Holm; Erik L L Sonnhammer; Sean R Eddy; Alex Bateman; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2011-11-29       Impact factor: 16.971

View more
  21 in total

1.  Synergistic Biophysical Techniques Reveal Structural Mechanisms of Engineered Cationic Antimicrobial Peptides in Lipid Model Membranes.

Authors:  Frank Heinrich; Aria Salyapongse; Akari Kumagai; Fernando G Dupuy; Karpur Shukla; Anja Penk; Daniel Huster; Robert K Ernst; Anna Pavlova; James C Gumbart; Berthony Deslouches; Y Peter Di; Stephanie Tristram-Nagle
Journal:  Chemistry       Date:  2020-04-28       Impact factor: 5.236

Review 2.  Intracellular Targeting Mechanisms by Antimicrobial Peptides.

Authors:  Cheng-Foh Le; Chee-Mun Fang; Shamala Devi Sekaran
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 3.  Platelet-Rich Plasma for the Treatment of Tissue Infection: Preparation and Clinical Evaluation.

Authors:  Wenhai Zhang; Yue Guo; Mitchell Kuss; Wen Shi; Amy L Aldrich; Jason Untrauer; Tammy Kielian; Bin Duan
Journal:  Tissue Eng Part B Rev       Date:  2019-05-15       Impact factor: 6.389

Review 4.  Antimicrobial Peptides: Mechanisms of Action and Resistance.

Authors:  B Bechinger; S-U Gorr
Journal:  J Dent Res       Date:  2016-11-25       Impact factor: 6.116

Review 5.  Developments and Applications of Functional Protein Microarrays.

Authors:  Guan-Da Syu; Jessica Dunn; Heng Zhu
Journal:  Mol Cell Proteomics       Date:  2020-04-17       Impact factor: 5.911

Review 6.  Anti-Microbial Peptides: Strategies of Design and Development and Their Promising Wound-Healing Activities.

Authors:  Fariba Fathi; Maryam Ghobeh; Maryam Tabarzad
Journal:  Mol Biol Rep       Date:  2022-05-08       Impact factor: 2.742

7.  Systemic Responses of Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Following Exposure to the Antimicrobial Peptide Cathelicidin-BF Imply Multiple Intracellular Targets.

Authors:  Cunbao Liu; Bin Shan; Jialong Qi; Yanbing Ma
Journal:  Front Cell Infect Microbiol       Date:  2017-11-07       Impact factor: 5.293

8.  Conjugation of Cell-Penetrating Peptides to Antimicrobial Peptides Enhances Antibacterial Activity.

Authors:  Hyunhee Lee; Sung In Lim; Sung-Heui Shin; Yong Lim; Jae Woong Koh; Sungtae Yang
Journal:  ACS Omega       Date:  2019-09-09

9.  Tachyplesin Causes Membrane Instability That Kills Multidrug-Resistant Bacteria by Inhibiting the 3-Ketoacyl Carrier Protein Reductase FabG.

Authors:  Cunbao Liu; Jialong Qi; Bin Shan; Yanbing Ma
Journal:  Front Microbiol       Date:  2018-05-01       Impact factor: 5.640

Review 10.  Non-Lytic Antibacterial Peptides That Translocate Through Bacterial Membranes to Act on Intracellular Targets.

Authors:  Marlon H Cardoso; Beatriz T Meneguetti; Bruna O Costa; Danieli F Buccini; Karen G N Oshiro; Sergio L E Preza; Cristiano M E Carvalho; Ludovico Migliolo; Octávio L Franco
Journal:  Int J Mol Sci       Date:  2019-10-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.